International Webinar:  the detection and treatment of ALK fusion-positive NSCLC 

Dr Ross et al in a discussion on the detection and treatment of ALK fusion-positive NSCLC in current practice

Published 31/01/24

You are about to leave Roche4Med website. Links to external web pages are offered for your convenience. Roche Pharmaceuticals (Israel) Ltd. is not responsible for the content displayed on those pages.